Literature DB >> 6420196

The role of arachidonic acid in vasogenic brain edema.

P H Chan, R A Fishman.   

Abstract

Arachidonic acid is released rapidly from cellular membrane phospholipids after pathological insults associated with the delayed development of brain edema. Intracerebral injection of arachidonic acid caused significant increases in brain water and sodium content with decreases in potassium content and Na+,K+-ATPase activity. The 125I-labeled bovine serum albumin spaces in brain (a measure of blood-brain barrier permeability) rose threefold 24 h after arachidonic acid injection. There was gross and microscopic evidence of edema. Saturated fatty acids and monounsaturated fatty acids were not effective. These data indicate that the endothelial cells of the blood-brain barrier are target sites for the action of arachidonic acid. It is hypothesized that the increased permeability of endothelial cells to macromolecules and water results from alterations of membrane phospholipids and increased vesicular transport, changes that are responsible for the delayed development of vasogenic edema.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6420196

Source DB:  PubMed          Journal:  Fed Proc        ISSN: 0014-9446


  17 in total

1.  Two components of blood-brain barrier disruption in the rat.

Authors:  A S Easton; M H Sarker; P A Fraser
Journal:  J Physiol       Date:  1997-09-15       Impact factor: 5.182

2.  Permeability and vasomotor response of cerebral vessels during exposure to arachidonic acid.

Authors:  A Unterberg; M Wahl; F Hammersen; A Baethmann
Journal:  Acta Neuropathol       Date:  1987       Impact factor: 17.088

3.  Interstitial glycerol as a marker for membrane phospholipid degradation in the acutely injured human brain.

Authors:  L Hillered; J Valtysson; P Enblad; L Persson
Journal:  J Neurol Neurosurg Psychiatry       Date:  1998-04       Impact factor: 10.154

4.  Experimental drug therapy of peritumoral brain edema.

Authors:  D E Weissman; C Stewart
Journal:  J Neurooncol       Date:  1988-12       Impact factor: 4.130

5.  Glucocorticoids in myocardial and cerebral infarction.

Authors:  M Koltai; A Tósaki; I Leprán; L Szekeres
Journal:  Agents Actions       Date:  1986-01

Review 6.  Pharmacological blood-brain barrier modification for selective drug delivery.

Authors:  T F Cloughesy; K L Black
Journal:  J Neurooncol       Date:  1995-11       Impact factor: 4.130

7.  Expression of vascular permeability factor in glioblastoma specimens: correlation with tumor vascular endothelial surface and peritumoral edema.

Authors:  J Vaquero; M Zurita; C Morales; R Cincu; S Oya
Journal:  J Neurooncol       Date:  2000-08       Impact factor: 4.130

8.  Soluble epoxide hydrolase inhibitor trans-4-[4-(3-adamantan-1-yl-ureido)-cyclohexyloxy]-benzoic acid is neuroprotective in rat model of ischemic stroke.

Authors:  Jafar Sadik B Shaik; Muzamil Ahmad; Wenjin Li; Marie E Rose; Lesley M Foley; T Kevin Hitchens; Steven H Graham; Sung Hee Hwang; Bruce D Hammock; Samuel M Poloyac
Journal:  Am J Physiol Heart Circ Physiol       Date:  2013-09-16       Impact factor: 4.733

9.  Leukotriene E4 selectively increase the delivery of methotrexate to the C6 gliomas in rats.

Authors:  C C Chio; S J Lin; M T Lin
Journal:  J Neurooncol       Date:  1995       Impact factor: 4.130

10.  Intra-arterial delivery of triolein emulsion increases vascular permeability in skeletal muscles of rabbits.

Authors:  Hak Jin Kim; Yong Woo Kim; In Sook Lee; Jong Woon Song; Yeon Joo Jeong; Seon Hee Choi; Kyung Un Choi; Kuen Tak Suh; Byung Mann Cho
Journal:  Acta Vet Scand       Date:  2009-07-16       Impact factor: 1.695

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.